Prevalence and predictors of fatigue in glioblastoma: A prospective study

Neuro-Oncology

Volumn 17, Issue 2, 2015, Pages 274-281

  Valko, Philipp O ^a   Siddique, Asim ^b   Linsenmeier, Claudia ^b   Zaugg, Kathrin ^b,c   Held, Ulrike ^d   Hofer, Silvia ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

depression; fatigue; glioblastoma; sleepiness

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CORTICOSTEROID;

ADULT; ARTICLE; CANCER FATIGUE; CHEMORADIOTHERAPY; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; EPWORTH SLEEPINESS SCALE; FATIGUE SEVERITY SCALE; FEMALE; GLIOBLASTOMA; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; NEUROSURGERY; PROSPECTIVE STUDY; SEX DIFFERENCE; SOMNOLENCE; SYMPTOMATOLOGY; TUMOR LOCALIZATION; BRAIN NEOPLASMS; COMPLICATION; FATIGUE; LONGITUDINAL STUDY; MIDDLE AGED; POSTOPERATIVE PERIOD; PREVALENCE; SEVERITY OF ILLNESS INDEX; SLEEP STAGE;

BRAIN NEOPLASMS; FATIGUE; FEMALE; GLIOBLASTOMA; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PREVALENCE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SLEEP STAGES;

EID: 84924962147     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nou127     Document Type: Article

References (44)

1. Louis DN, Ohgaki H, Wiestler OD, et al. WHO Classification of Tumours of the Central Nervous System. Lyon: IARC: 2007.
2. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996.
3. Johnson DR, Ma DJ, Buckner JC, et al. Conditional probability of long-term survival in glioblastoma: a population-based analysis. Cancer. 2012;118(22):5608-5613.
4. Campos MP, Hassan BJ, Riechelmann R, et al. Cancer-related fatigue: a practical review. Ann Oncol. 2011;22(6):1273-1279.
5. Armstrong TS, Cron SG, Bolanos EV, et al. Risk factors for fatigue severity in primary brain tumor patients. Cancer. 2010;116(11): 2707-2715.
6. Berger AM, Abernethy AP, Atkinson A, et al. Cancer-related fatigue. J Natl Compr Canc Netw. 2010;8(8):904-931.
7. Stone P, Richardson A, Ream E, et al. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol. 2000;11(8):971-975.
8. Lis CG, Rodeghier M, Grutsch JF, et al. Distribution and determinants of patient satisfaction in oncology with a focus on health related quality of life. BMC Health Serv Res. 2009;9:190.
9. Armstrong TS, Gilbert MR. Practical strategies for management of fatigue and sleep disorders in people with brain tumors. Neuro Oncol. 2012;4(suppl. 4):iv65-iv72.
10. Winningham ML, Nail LM, Burke MB, et al. Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum. 1994; 21(1):23-36.
11. Pachman DR, Barton DL, Swetz KM, et al. Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol. 2012;30(30):3687-3696.
12. Taphoorn MJ, Stupp R, Coens C, et al. Health-related quality of life in patients with glioblastoma: A randomized controlled trial. Lancet Oncol. 2005;6(12):937-944.
13. Faithfull S, Brada M. Somnolence syndrome in adults following cranial irradiation for primary brain tumours. Clin Oncol. 1998; 10(4):250-254.
14. Lovely MP, Miaskowski C, Dodd M. Relationship between fatigue and quality of life in patients with glioblastoma multiformae. Oncol Nurs Forum. 1999;26(5):921-925.
15. Hjollund NH, Andersen JH, Bech P. Assessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales. Health Qual Life Outcomes. 2007;5:12.
16. Brown PD, Ballman KV, Rummans TA, et al. Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol. 2006;76(3):283-291.
17. Flechl B, Ackerl M, Sax C, et al. Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors. J Neurooncol. 2012;109(2):331-339.
18. Flechl B, Ackerl M, Sax C, et al. The caregivers' perspective on the end-of-life phase of glioblastoma patients. J Neurooncol. 2013; 112(3):403-411.
19. Valko PO, Bassetti CL, Bloch KE, et al. Validation of the fatigue severity scale in a Swiss cohort. Sleep. 2008;31(11):1601-1607.
20. Valko PO, Waldvogel D, Weller M, et al. Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment. Eur J Neurol. 2010;17(12):1428-1436.
21. Cronbach LJ. Coefficient alpha and the internal structure of test. Psychometrika. 1951;16(3):97-102.
22. Bloch KE, Schoch OD, Zhang JN, et al. German version of the Epworth Sleepiness Scale. Respiration. 1999;66(5): 440-447.
23. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-370.
24. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results. J Psychosom Res. 1997;42(1):17-41.
25. Drappatz J, Schiff D, Kesari S, et al. Medical management of brain tumor patients. Neurol Clin. 2007;25(4):1035-1071.
26. Powell C, Guerrero D, Sardell S, et al. Somnolence syndrome in patients receiving radical radiotherapy for primary brain tumours: a prospective study. Radiother Oncol. 2011;100(1): 131-136.
27. Struik K, Klein M, Heimans JJ, et al. Fatigue in low-grade glioma. J Neurooncol. 2009;92(1):73-78.
28. Hossain JL, Ahmad P, Reinish LW, et al. Subjective fatigue and subjective sleepiness: two independent consequences of sleep disorders?. J Sleep Res. 2005;14(3):235-253.
29. Baumann CR, Werth E, Stocker R, et al. Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study. Brain. 2007;130(7):1873-1883.
30. Fronczek R, Overeem S, Lee SY, et al. Hypocretin (orexin) loss in Parkinson's disease. Brain. 2007;130(6):1577-1585.
31. Baumann CR, Bassetti CL, Valko PO, et al. Loss of hypocretin (orexin) neurons with traumatic brain injury. Ann Neurol. 2009; 66(4):555-559.
32. Harrington ME. Neurobiological studies of fatigue. Prog Neurobiol. 2012;99(2):93-105.
33. Billiard M, Dolenc L, Aldaz C, et al. Hypersomnia associated with mood disorders: A new perspective. J Psychosom Res. 1994; 38(suppl. 1):41-47.
34. Gaston-Johansson F, Fall-Dickson JM, Bakos AB, et al. Fatigue, pain, and depression in pre-autotransplant breast cancer patients. Cancer Pract. 1999;7(5):240-247.
35. Bower JE, Ganz PA, Desmond KA, et al. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18(4):743-753.
36. Litofsky NS, Resnick AG. The relationships between depression and brain tumors. J Neurooncol. 2009;94(2):153-161.
37. Gainotti G. Emotional behavior and hemispheric side of lesion. Cortex. 1972;8(1):41-55.
38. Irle E, Peper M, Wowra B, et al. Mood changes after surgery for tumors of the cerebral cortex. Arch Neurol. 1994;51(2):164-174.
39. Pringle AM, Taylor R, Whittle IR. Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg. 1999;13(1):46-51.
40. Klein M, Taphoorn MJB, Heimans JJ, et al. Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol. 2001;19(20):4037-4047.
41. Rooney AG, Carson A, Grant R. Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst. 2011;103(1):61-76.
42. Carson AJ, MacHale S, Allen K, et al. Depression after stroke and lesion location: a systematic review. Lancet. 2000;356(9224):122-126.
43. Soffietti R, Kocher M, Abacioglu UM, et al. A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol. 2013;31(1):65-72.
44. Hinz A, Krauss O, Hauss JP, et al. Anxiety and depression in cancer patients compared with the general population. Eur J Cancer Care. 2010;19(4):522-529.